IHCV - Israel Health Care Ventures   Getting The Best Out Of Life Sience
 
 
 

Israel HealthCare Ventures

Israel HealthCare Ventures (IHCV) provides venture capital investment to Israeli and Israeli related companies in the fields of medical devices, biotechnology, pharmaceuticals, and medical-related IT. Headquartered in Tel Aviv, IHCV was founded in March 2001 by prominent US and European investors from the pharmaceutical and financial services worlds. It is led by highly experienced medical analysts and advisors. IHCV takes a hands-on approach, providing portfolio companies with clinical advice, management consulting and an extensive network of contacts throughout the global medical and financial fields


 


News

Orsense Ltd.
OrSense Receives FDA Clearance for its Noninvasive Hemoglobin Monitor


Orsense Ltd.
OrSense Non Invasive Hemoglobin Monitor Received CFDA Approval for Marketing in ...


Argo Medical Technologies Ltd.
ARGO Medical Technologies Announces Strategic Partnership with YASKAWA Electric Company


Gamida Cell Ltd.
Gamida Cell Announces the Successful Transplantation of the First Patient in ...


Orsense Ltd.
OrSense Non Invasive Hemoglobin Monitor Shown Safe and Accurate for Pre-Donation ...


NanoPass Technologies Ltd.
NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine ...


Gamida Cell Ltd.
Gamida Cell Reports StemEx® Phase II/III Study Safety and Efficacy Data ...


NanoPass Technologies Ltd.
IDRI and Medicago to present data at the World Vaccine Congress ...


Argo Medical Technologies Ltd.
President Obama Views Demonstration of ReWalk Exoskeleton Technology During Visit to ...


Gamida Cell Ltd.
Gamida Cell’s StemEx® Achieves Primary Endpoint in Phase II/III Clinical Study ...


Argo Medical Technologies Ltd.
ARGO Medical Technologies Unveils Advancement of its Exoskeleton Technology with Launch ...


HomeSkinovations Ltd.
Silk'n Partners with Bed Bath & Beyond Silk'n Flash&Go Now Available at ...


NanoPass Technologies Ltd.
NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for ...


Gamida Cell Ltd.
First Pediatric Sickle Cell Disease Patient Receives NiCord® Stem Cell Transplantation ...


Argo Medical Technologies Ltd.
ARGO Medical Technologies Announces European Commercial Launch of the ReWalk Exoskeleton ...


Orsense Ltd.
OrSense Non Invasive Hemoglobin Monitor Gains Worldwide Recognition as a Safe, ...


Argo Medical Technologies Ltd.
Governor Patrick Joins Israeli-Founded ARGO Medical Technologies to Announce Selection of ...


Gamida Cell Ltd.
Gamida Cell Completes Enrollment for Phase I/II Study of Second Pipeline ...


Argo Medical Technologies Ltd.
New Era Starts as ReWalk Exoskeleton Technology is Available to Take ...


NanoPass Technologies Ltd.
NanoPass Secures Series B Investment to Accelerate Commercialization of its Intradermal ...


Orsense Ltd.
OrSense Introduces Glasswing, its Next-Generation, Wireless, Non-Invasive Hemoglobin Monitoring System for ...


OrSense Ltd.
OrSense detects hemorrhage, anemia during pregnancy


NovoGI Inc.
novoGI(TM) Announces Purchase of IP and Collaboration With Leading Gastroenterologist Dr. ...


NovoGI Inc.
novoGI™ Announces New Studies on Compression Anastomosis Presented at the Annual ...


NovoGI Inc.
novoGI Led by Gavriel Meron to Provide Novel Solutions for GI ...


CardioDex Ltd.
New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety ...


Gamida Cell Ltd.
The Gamida Cell-Teva Joint Venture Concludes Enrollment for the Phase III ...


D-Pharm Ltd.
D Pharm expands Chinese cooperation agreement. The agreement with Wanbang Biopharmaceuticals ...


D-Pharm Ltd.
D-Pharm announces expected date of interim report for the DP-b99 Acute ...


OrSense Ltd.
OrSense's Non-Invasive Hemoglobin Measurement System for Pre-Donation Screening of Anemia Delivers ...


Gamida Cell Ltd.
The Gamida Cell-Teva Joint Venture Receives Green Light From the Data ...


D-Pharm Ltd.
DP-b99 Phase III MACSI Study Protocol Published in International Journal of ...


OrSense Ltd.
OrSense`s Non Invasive Hemoglobin Monitor has the Potential to Enhance Recruitment ...


OrSense Ltd.
OrSense Closes U.S. $18 Million Private Financing to Accelerate Commercialization of ...


D-Pharm Ltd.
D-Pharm receives Fast Track designation from FDA for DP-b99 stroke


Home Skinovations Ltd.
Silk'n Wins About.Com's 2011 Readers' Choice Awards for Best Laser or ...


D-Pharm Ltd.
D-Pharm Ltd appoints CRO for clinical development of DP-b99 in China ...


OrSense Ltd.
OrSense Continuous Non Invasive Hemoglobin Monitoring System Demonstrates Accurate Performance During ...


OrSense Ltd.
OrSense Non Invasive Hemoglobin Monitoring Enables Accurate Anemia Screening


OrSense Ltd.
OrSense Introduces Non-Invasive Hemoglobin System for Anemia Monitoring in Maternal Health ...


D-Pharm Ltd.
D-Pharm is Shortlisted for Scrip 2010 Award.


D-Pharm Ltd.
D-Pharm Receives Top-line Results From Cardiac Safety Study with DP-b99


OrSense Ltd.
OrSense Presents Non-Invasive Hemoglobin Monitoring System for Anemia Monitoring, Hemorrhage Detection ...


Gamida Cell Ltd.
The Gamida Cell-TEVA Joint Venture Receives FDA Fast Track Designation for ...


NiTi Surgical Solutions
NiTi Surgical Solutions Announces Application Milestone and Clinical Data Supporting Lead ...


OrSense Ltd.
OrSense Ltd. Receives U.S. FDA Approval for NMB-200MP Non-Invasive Oximetry Monitoring ...


Gamida Cell Ltd.
Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx®, ...


Gamida Cell Ltd.
European Medicines Agency (EMA) Waives Requirement to Test StemEx® in Paediatric ...


D-Pharm Ltd.
D-Pharm (DPRM: TASE) Announces Enrollment of First Patient in DP-b99 Phase ...


Optonol Ltd.
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol


Gamida Cell Ltd.
Gamida Cell Announces Feasibility Study with Weill Cornell Medical College Study is ...


D-Pharm Ltd.
D-Pharm Enters into Collaboration with Wanbang Biopharmaceuticals to Increase the Potential ...


Gamida Cell Ltd.
StemEx® Noted as a Reliable Investigational Product of an Expanded Population ...


Gamida Cell Ltd.
Gamida Cell and Cellerix Partner on Feasibility Study Pre-clinical study will ...


OrSense Ltd.
OrSense`s NBM-200MP System for Continuous Non-Invasive Hemoglobin and Blood Oximetry Measurements ...


Home Skinovations Ltd.
Silk'n SensEpil TM Launches at Saks Fifth Avenue Stores Around the ...


Gamida Cell Ltd.
Article Published in Expert Opinion on Biological Therapy Evaluates StemEx® (carlecortemcel-l) ...


Gamida Cell Ltd.
Children’s Hospital in Colorado Rounds off List of 24 Cord Blood ...


D-Pharm Ltd.
D-Pharm raises NIS 85 Million in rights offering and Initial Public ...


NiTi Surgical Solutions
NiTi Surgical Solutions Secures $18.5 Million in Series F Financing


Home Skinovations Ltd.
Introducing Silk’n Sensepil™ The Newest Beauty Breakthrough & Smoothest Skin Solution ...


D-Pharm Ltd.
D-Pharm Receives FDA Clearance to Commence a Phase III Trial of ...


Optonol Ltd.
Comparison of Ex-PRESS miniature implant with standard trabeculectomy ...


Mazor Surgical Technologies
GO-LIF™ Received CE Clearance: Mazor Accelerates Its International Multi-Center Clinical Trial ...


Gamida Cell Ltd.
President of Israel Shimon Peres Tours Gamida Cell in Jerusalem


D-Pharm Ltd.
D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to ...


NiTi Surgical Solutions
NiTi Surgical Solutions Announces U.S. Launch of Revolutionary ColonRing™ Surgical Device ...


OrSense Ltd.
OrSense Receives European CE Mark Approval for Continuous Non-Invasive Hemoglobin and ...


Gamida Cell Ltd.
The Western Pennsylvania Hospital Joins Prominent Group of Cancer Centers Exploring ...


OrSense Ltd.
OrSense Launches System for Continuous Non-Invasive Hemoglobin and Blood Oximetry Measurements ...


CorAssist Cardiovascular Ltd.
CorAssist Raises $5.25 Million In Private Financing Advancing The First Therapeutic Devices ...


Mazor Surgical Technologies
Mazor Begins an International Multicenter Clinical Trial for GO-LIF™ (Guided Oblique ...


NiTi Surgical Solutions
Colorectal Surgery Patients May Recover Faster, Experience Fewer Complications With Revolutionary ...


CorAssist Cardiovascular Ltd.
CorAssist Proves Efficacy In Animals And Shows 3 Months Safety In ...


Mazor Surgical Technologies
Mazor Surgical Technologies’ latest development for spinal surgeries GO-LIF™ achieved a critical ...


Medigus
Positive results from additional human clinical trials the company has ...


Mazor Surgical Technologies
The Centers for Medicare and Medicaid Services in the US issues ...


Mazor Surgical Technologies
Mazor Surgical Technologies Receives FDA Clearance For Its C-Insight™ System


Gamida Cell Ltd.
Gamida Cell Announces License Agreement with Amgen to Support Development and ...


Gamida Cell Ltd.
Gamida-Cell Signs Collaboration Agreement with Biologics Delivery Systems


Medigus
Medigus announces that on June 1, 2008, a term sheet was ...


Mazor Surgical Technologies
Mazor Surgical Technologies enters into an Exclusive Worldwide License with the ...


D-Pharm Ltd.
D-Pharm secures funding from Israel's Chief Scientist's Office


CorAssist Cardiovascular Ltd.
CorAssist is proud to announce FIM (First in Man) implantation in ...


Home Skinovations Ltd.
Silk’n™ Personal Light-Based Hair Removal Device Cleared by FDA.


Medigus
Medigus hereby announces that it has received an immediate approval from ...


D-Pharm Ltd.
D-Pharm completes Pre-IND meeting with the FDA for treatment of acute ...


Medigus
Medigus hereby announces that on December 26, 2007, positive results were ...


CorAssist Cardiovascular Ltd.
CorAssist completed Pre-IDE meeting with the FDA


Mazor Surgical Technologies
The "Bill Gates" Of Spine Joins Mazor’s Advisory Board Father of many ...


Gamida Cell Ltd.
First Patient Undergoes Expanded Cord Blood Transplant


CorAssist Cardiovascular Ltd.
CorAssist has completed preliminary proof of concept for the ImCardia™ MIS ...


Mazor Surgical Technologies
Mazor Launches New Product: A Bed Mounted Minitaure Robotic Device Enables spine ...


Mazor Surgical Technologies
Mazor Debuts Spineassist Application For Cervical Implant Placement The application answers surgeons' ...


OrSense Ltd.
From Forbes Magazine: New Devices Shine a Light on Blood Sugar ...


OrSense Ltd.
OrSense Receives European CE Mark Approval for Continuous Non-Invasive Glucose Monitoring ...


Mazor Surgical Technologies
Mazor Spineassist Delivers 98 Percent Reduction In Surgeon Radiation Exposure Spinal Guidance ...


OrSense Ltd.
OrSense Receives Technology Innovation Award for Continuous Non-Invasive Glucose Monitoring System ...


OrSense Ltd.
OrSense: Accurate Non-Invasive CGM


Medigus
Medigus hereby notifies the results of the company's IPO, based on ...


Syneron Medical Ltd.
Syneron Announces Closing of Secondary Offering


Syneron Medical Ltd.
SYNERON Announces Closing of IPO Syneron Medical Ltd. (Nasdaq: ELOS) announced today ...


 
 
 -   -   -   - 
Tel. +972 3 648-8566 | Fax. +972 3 648-8474 | Email: ihcv@ihcv.co.il | www.ihcv.co.il | Address: 32 Habarzel St. Tel Aviv 69710
© 2008 IHCV   netbiz multimedia - פתרונות מולטימדיה וסלולר